NCT07200609Not yet recruiting
The Effects of Virtual Reality-Based Gamified Rehabilitation in Children With Hemophilia
The Effects of a Virtual Reality-Based Gamified Rehabilitation Program on Body Structure and Function, Activity, and Participation in Children With Hemophilia: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 1 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Hemophilia is an inherited bleeding disorder caused by deficiencies or low levels of clotting factors VIII (hemophilia A) and IX (hemophilia B). It is a chronic disease that negatively affects physical function, mobility, and quality of life by causing damage to joint and muscle structures due to bleeding disorders. Traditional rehabilitation methods can sometimes be boring for children and lead to a loss of motivation. Therefore, there is a need for innovative methods that will increase treatment compliance and improve children's physical activity levels. Virtual reality (VR) technology provides a realistic and interactive environment that enables children to actively participate in the rehabilitation process. Combined with gamification elements, VR offers a fun learning and practice environment that supports the development of motor skills, reduces fear of movement, and can increase motivation for repetitive exercises. This randomized controlled trial will evaluate the effects of virtual reality-based gamified rehabilitation on joint health, pain, posture, gait function, proprioception, and quality of life. Additionally, the contribution of this intervention to changes in activity and participation levels will be demonstrated using the International Classification of Functioning, Disability, and Health (ICF) model. This study has the potential to guide future clinical practice by offering a more enjoyable and effective rehabilitation alternative for children with hemophilia. The widespread adoption of virtual reality-supported programs will be an important step in reducing physical disabilities associated with hemophilia.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 11 Sept 2025
- Start date
- 1 Nov 2025
- Primary completion date
- 30 Apr 2026
- Lead sponsor
- Hacettepe University
- Diseases
- Haemophilia
- NCT number
- NCT07200609
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 1 Nov 2025 to the primary completion date, 30 Apr 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Those who have had lower extremity surgery
Other illness
- Children with active bleeding
- Children with neurological, orthopedic, or psychological illnesses that may affect functional performance
Other
- Those with mental retardation
Who the study is looking for
- Hemophilia A diagnosed by a pediatric hematologist
- Boys aged 6-18
- Have moderate to severe hemophilia
- Do not exercise regularly
- Be able to move independently or with minimal support (ambulatory)
- Have the capacity to understand research instructions
- Prevent active bleeding
- Voluntary participation in expenses and parental record keeping
- Continued prophylactic treatment
Age in the registry: 6 years to 18 years · Sex: Male · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.